Malaria vaccines in India: Bridging the gap between hope and reality

Shambo Samrat Samajdar , Rupak Chatterjee , Shatavisa Mukherjee , Nandini Chatterjee , Shravan Venkatraman

One Health Bulletin ›› 2025, Vol. 5 ›› Issue (4) : 147 -148.

PDF (242KB)
One Health Bulletin ›› 2025, Vol. 5 ›› Issue (4) :147 -148. DOI: 10.4103/ohbl.ohbl_5_25
Perspective
research-article
Malaria vaccines in India: Bridging the gap between hope and reality
Author information +
History +
PDF (242KB)

Cite this article

Download citation ▾
Shambo Samrat Samajdar, Rupak Chatterjee, Shatavisa Mukherjee, Nandini Chatterjee, Shravan Venkatraman. Malaria vaccines in India: Bridging the gap between hope and reality. One Health Bulletin, 2025, 5 (4) : 147-148 DOI:10.4103/ohbl.ohbl_5_25

登录浏览全文

4963

注册一个新账户 忘记密码

Conflict of interest statement

The authors declare that there is no conflict of interest.

Funding

This study received no extramural funding.

Data availability statement

Data sharing is not applicable to this article as no new data were created or analyzed in this study.

Authors’ contributions

Samajdar SS, Chatterjee R, and Venkatraman S conceptualized and designed the manuscript. Mukherjee S and Chatterjee N were responsible for gathering relevant literature and supporting data. Samajdar SS, Chatterjee R, and Venkatraman S drafted the initial manuscript. Mukherjee S contributed substantially to the writing and editing process. Chatterjee N and Venkatraman S critically revised the manuscript for important intellectual content. All authors reviewed and approved the final version of the manuscript. Samajdar SS, Chatterjee R and Venkatraman S are the guarantors of the paper.

References

[1]

Ahmed RA, Kumar A, Swargiary A, Suri HS, Shankar H, Hussain SSA, et al. Impact assessment of Intensified Malaria Control Project in transitioning a high malaria-endemic district to a low-endemic district: An epidemiological aspect. Pathog Glob Health 2023; 117(5): 493-504.

[2]

Singh MP, Rajvanshi H, Bharti PK, Anvikar AR, Lal AA. Time series analysis of malaria cases to assess the impact of various interventions over the last three decades and forecasting malaria in India towards the 2030 elimination goals. Malar J 2024; 23(1): 50.

[3]

Rahi M, Sharma A. For malaria elimination, India needs to integrate its research and control arms. Am J Trop Med Hyg 2024; 111(2): 226-229.

[4]

Narain JP, Nath LM. Eliminating malaria in India by 2027. The countdown begins! Indian J Med Res 2018; 148(2): 123-126.

[5]

El-Moamly AA, El-Sweify MA. Malaria vaccines: The 60-year journey of hope and final success-lessons learned and future prospects. Trop Med Health 2023; 51(1): 29.

[6]

Laurens MB. Novel malaria vaccines. Hum Vaccin Immunother 2021; 17(11): 4549-4552.

[7]

Duffy PE. Current approaches to malaria vaccines. Curr Opin Microbiol 2022; 70: 102227.

[8]

Nitika N, Nema S, Bharti PK. R21 vaccine: A ray of hope for malaria elimination. Asian Pac J Trop Med 2023; 16(6): 243-244.

[9]

Nadeem A, Bilal W. Acceptance, availability and feasibility of RTS, S/AS01 malaria vaccine: A review of literature. Asian Pac J Trop Med 2023; 16(4): 162-168.

[10]

Genton B. R21/Matrix-M™ malaria vaccine: A new tool to achieve WHO’s goal to eliminate malaria in 30 countries by 2030? J Travel Med 2023; 30(8): 140.

[11]

Datoo MS, Dicko A, Tinto H, Ouédraogo JB, Hamaluba M, Olotu A, et al. Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: A multicentre, double-blind, randomised, phase 3 trial. Lancet 2024; 403(10426): 533-544.

[12]

Singhal C, Aremu TO, Garg P, Shah K, Okoro ON. Awareness of the malaria Vaccine in India. Cureus 2022; 14(9): e29210.

PDF (242KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

/